Medical devices, healthcare technology and the business of care
510(k) clearance · K253393

Single-use Balloon Dilatation Catheter (AG-5251-083018 AG-5251-085518 AG-5251-088018 AG-5251-083019 AG-5251-085519 AG-5251-088019 AG-5251-083021 AG-5251-085521 AG-5251-088021 AG-5251-083024 AG-5251-085524 AG-5251-088024 AG-5251-103018 AG-5251-105518 AG-5251-108018 AG-5251-103019 AG-5251-105519 AG-5251-108019 AG-5251-103021 AG-5251-105521 AG-5251-108021 AG-5251-103024 AG-5251-105524 AG-5251-108024 AG-5251-123018 AG-5251-125518 AG-5251-128018 AG-5251-123019 AG-5251-125519 AG-5251-128019

Hangzhou AGS MedTech Co., Ltd. · Decision date Jun 24, 2026

FDA DECISIONK253393

What did the FDA decide?

FDA records K253393 as a 510(k) premarket notification, with a decision dated Jun 24, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Gastroenterology, Urology
Decision date
Jun 24, 2026

FDA source record

Regulatory record facts

Identifier
K253393
Regulatory pathway
510(k) premarket notification
Product code
FGE
Decision code
SESE
Decision date
Jun 24, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Stents, Drains And Dilators For The Biliary Ducts.

Product code
FGE
FDA device class
2

FDA decision timeline

  1. K253393 received

    Application receipt date recorded by FDA.

  2. K253393 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code FGE

Product / regulatory recordCompanyPathwayDecision dateSource
Canyon Medical Inc.510(k) clearanceSep 18, 2026FDA
Medtronic, Inc.510(k) clearanceSep 17, 2026FDA
Q3 Medical USA, LLC (C/O Q3 Medical Devices Ltd.)510(k) clearanceJul 27, 2026FDA
Mirco-Tech (Nanjing) Co., Ltd.510(k) clearanceApr 24, 2026FDA
Medi-Globe GmbH510(k) clearanceApr 16, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Hangzhou AGS MedTech Co., Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Hangzhou

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records